Nevro Corp (NVRO): Market Cap to Revenue

Symbol and logo of brand Nevro Corp (NVRO)

Nevro Corp. is implementing robotic electrode assembly to enhance implant precision. Management aims to validate the efficacy of its systems across various pain types, while the strategy focuses on cost optimization and maintaining margins. The price/sales multiple reflects the business valuation dynamics, where 0.50 determines the current status of the parameter relative to historical revenue volatility.

NVRO Nevro Corp P/S Multiple (07/04/2022 - 04/13/2025)

Analytical breakdowns for Nevro Corporation (NVRO)

- share price and consensus valuation forecast:
Price Performance Chart nevro.com|NVRO - Price Target Chart
- stock exchange capitalization data:
Market Valuation Nevro Corporation|NVRO - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Nevro|NVRO - Book Capitalization|Capitalization to Book Value Ratio nevro.com|NVRO - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Nevro Corp.|NVRO - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Nevro Medical|NVRO - Company Aggregate Debts|Debts to Book Capitalization Nevro Corporation|NVRO - Company Long-Term Debt|Company Short-Term Debt Nevro|Intermediate Coverage Ratio nevro.com
- earnings and multiples data:
NVRO - Net Profit|Expected Net Profit Nevro Corp.|NVRO - Price to Earnings Ratio|Forward Price to Earnings Multiple Nevro Corp|NVRO - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Nevro Corporation|NVRO - Operating profit EBITDA|Net earnings per share for the last four quarters Nevro|NVRO - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months nevro.com|NVRO - Earnings per share growth in current year|Expected earnings per share growth for next year Nevro Corp.
- issuer revenue and sales details:
NVRO - Revenue and Sales Volume|Company Expected Sales Volume nevro.com|NVRO - Price-to-Revenue Ratio|Market Cap to Projected Revenue Nevro Corporation
General company analysis:NVRO nevro.com
Core merchandise of Nevro Corp.

Investors evaluate the capitalization of Nevro Corp. (NVRO) using the price-to-sales ratio, which determines the price per unit of revenue. Fundamental P/S analysis allows market expectations to be compared with the uniqueness of HF10 technology and the 10 kHz frequency patents that create a technological barrier. The fundamental P/S trend helps identify overbought zones, minimizing the risks of entering at valuation peaks.

Competitors of Nevro Corp.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|beyondair.net (XAIR) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio PFSA|SSKN (STRATA Skin Sciences Inc.) - P/S Multiple|Price to Sales glucotrack.com GCTK|Market Cap to Revenue NAOV (NanoVibronix)|Price-to-Revenue Ratio VERO (Venus Concept Corporation)|Price-to-Revenue Ratio Nuwellis, Inc. NUWE|Market Capitalization-to-Revenue Ratio AEMD|ASXC - Price-to-Revenue Ratio|Price to Sales Avinger Inc.|BSGM (BioSig Technologies, Inc) - Market Cap to Revenue|Cutera Inc - Market Capitalization-to-Revenue Ratio|KNW (Know Labs, Inc.) - P/S Multiple|Market Cap to Revenue inarimedical.com (NARI)|Price-to-Revenue Ratio ReShape Lifesciences (RSLS)|SILK - Price to Sales